Back to top

SECOND AMENDED AND RESTATED CALL OPTION AGREEMENT

Option Agreement

SECOND AMENDED AND RESTATED CALL OPTION AGREEMENT | Document Parties: AMERICAN CAPITAL STRATEGIES, LTD | AMERICAN CAPITAL EQUITY I, LLC | Dosimetry Acquisitions (U.S.), LLC You are currently viewing:
This Option Agreement involves

AMERICAN CAPITAL STRATEGIES, LTD | AMERICAN CAPITAL EQUITY I, LLC | Dosimetry Acquisitions (U.S.), LLC

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: SECOND AMENDED AND RESTATED CALL OPTION AGREEMENT
Governing Law: California     Date: 8/13/2009

SECOND AMENDED AND RESTATED CALL OPTION AGREEMENT, Parties: american capital strategies  ltd , american capital equity i  llc , dosimetry acquisitions (u.s.)  llc
50 of the Top 250 law firms use our Products every day

Exhibit 10.15

SECOND AMENDED AND RESTATED CALL OPTION AGREEMENT
AMONG
AMERICAN CAPITAL STRATEGIES, LTD.,
AMERICAN CAPITAL EQUITY I, LLC,
AMERICAN CAPITAL EQUITY II, LLC,
AND
THOMAS D. LOGAN

          SECOND AMENDED AND RESTATED CALL OPTION AGREEMENT (this “ Agreement ”), entered into this ___ day of December, 2007 by and among AMERICAN CAPITAL STRATEGIES, LTD., a corporation existing under the laws of the State of Delaware (“ ACS ”), AMERICAN CAPITAL EQUITY I, LLC, a limited liability company existing under the laws of the State of Delaware (“ ACE I ”), AMERICAN CAPITAL EQUITY II, LLC, a limited liability company existing under the laws of the State of Delaware (“ ACE II ”, together with ACE I, “ ACE ”, and together with ACS, “ ACAS ”), and THOMAS D. LOGAN (“ Logan ”).

          WHEREAS, as of the date hereof, the Major Investor (as defined below) is the owner of shares of Preferred Stock, Warrants and Class B Common Stock (each as defined below), of Mirion Technologies, Inc., a Delaware corporation (the “ Company ”);

          WHEREAS, in connection with the Master Restructuring Agreement and Plan of Merger dated as of December 22, 2005, and effective as of December 31, 2005, the Company became the sole stockholder of each of Global Dosimetry Solutions (“ GDS ”), Dosimetry Acquisitions (U.S.), LLC (“ Dosimetry ”) and IST Acquisitions, Inc. (“ IST ”);

          WHEREAS, pursuant to the Call Option Agreement between ACS and Logan dated April 19, 2004, Logan was granted certain rights to purchase common stock of GDS and Dosimetry from the Major Investor (the “ Original Agreement ”);

          WHEREAS, the Original Agreement was amended and restated on August 18, 2006 (the “ Amended and Restated Agreement ”) to provide Logan with a call option to purchase shares of Class A Common Stock (as defined below) from the Major Investor; and

          WHEREAS, each of ACAS and Logan desires to amend and restate the Amended and Restated Agreement to add an ROI (as defined below) component to the vesting of Logan’s IRR Options and to add ACE I and ACE II as parties hereto.

          NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants herein contained, the parties hereto hereby agree as follows:

ARTICLE I

DEFINITIONS

 


 

Terms not otherwise defined in the text of this Agreement shall have the following meanings:

          1.1 “ Affiliate ” shall mean any entity controlling, controlled by or under common control with ACAS.

          1.2 “ Business Day ” shall mean any day of the year on which national banking institutions in New York, New York and Orange County, California are open to the public for conducting business and are not required or authorized to close.

          1.3 “ Cash Inflows ” as used herein shall include payments of dividends, distributions, redemptions, premiums and proceeds received by the Major Investor in connection with the Investment, excluding any structuring, management or other fees or the reimbursement of any expenses received by the Major Investor in connection therewith.

          1.4 “ Cash Outflows ” as used herein shall mean the purchase price paid by the Major Investor for the Investment.

          1.5 “ Change of Control ” shall mean a transaction or a series of related transactions involving:

          (a) The sale of fifty-one percent (51%) or more of the assets (based on their fair market value) of the Company; or

          (b) The sale by the Major Investor or stockholders of the Company in a single transaction or in a series of related transactions of equity securities constituting greater than fifty percent (50%) of the voting power of the equity securities of the Company; or

          (c) Any consolidation, merger or recapitalization of the Company in which the Company is not the continuing or surviving corporation or pursuant to which the Company’s voting stock would be converted into cash, securities and/or other property, other than any such transaction in which holders of the Company’s voting stock immediately before the transaction, in the aggregate, have (or upon conversion, exercise or similar action would have) on the same proportionate basis that existed prior to the transaction, more than fifty percent (50%) of the voting power of all issued and outstanding securities of the surviving corporation after the transaction.

For the avoidance of doubt, the conversion of Preferred Stock into Common Stock by the Major Investor shall not be deemed a “ Change of Control ”.

          1.6 “ Class A Common Stock ” shall mean the Company’s Class A Common Stock, par value $.001 per share.

          1.7 “ Class B Common Stock ” shall mean the Company’s Class B Common Stock, par value $.001 per share.

2


 

          1.8 “ Common Stock ” shall mean the Class A Common Stock and the Class B Common Stock.

          1.9 “ Fully Diluted Basis ” shall mean the total number of shares of Common Stock which are issued and outstanding plus the total number of shares of Common Stock which would be issued and outstanding assuming the exercise of all outstanding options issued pursuant to the Company’s 2006 Stock Plan, the exercise of all warrants or rights to purchase Common Stock and the conversion of all outstanding securities, including the Preferred Stock.

          1.10 “ Investment ” shall mean any investment, whether before or after the date hereof, in any equity security (or security convertible into equity) of the Company or any subsidiary thereof by the Major Investor, including, for the avoidance of doubt, the Preferred Stock, Warrants and Common Stock and any investment in any equity security of each of GDS, Dosimetry and IST.

          1.11 “ IPO ” shall mean an initial public offering of Common Stock in an underwritten offering under the Securities Act of 1933, as amended.

          1.12 “ IRR ” shall mean the interest rate (compounded annually) determined using the XIRR function of the Microsoft Excel program that, when used to calculate the net present value of all Cash Inflows and all Cash Outflows, causes such net amount to equal zero, and shall be calculated at the times and in the manner set forth herein.

          1.13 “ Logan Employment Agreement ” shall mean the Employment Agreement between Logan and the Company dated as of the date hereof, as amended from time to time.

          1.14 “ Major Investor ” shall mean ACAS, together with its Affiliates, or any successor or assign (provided that such successor or assign is a successor or assign of all or a material part of the assets of ACAS and its Affiliates).

          1.15 “ Preferred Stock ” shall mean the Series A-1 Convertible Participating Preferred Stock and Series A-2 Convertible Participating Preferred Stock of the Company, par value $.001 per share.

          1.16 “ ROI ” shall be calculated by dividing (x) the amount of cash return received by the Major Investor in respect of the equity securities being transferred or sold in connection with a Change of Control or IPO, as applicable, by (y) the amount of total cash Investment made in such equity securities.

          1.17 “ Warrants ” shall mean the warrants to purchase shares of Class A Common Stock.

3


 

ARTICLE II

IRR CALL OPTIONS

          2.1 Grant of IRR Call Option . Subject to the terms hereof, the Major Investor hereby grants Logan the option (the “ IRR Call Option ”) to purchase from the Major Investor up to 54,564 shares of Class A Common Stock (the “ IRR Option Shares ”). The IRR Call Option is exercisable at a price of $88.75 per share (the “ IRR Exercise Price ”).

          2.2 Vesting of IRR Option Shares . No IRR Option Share shall be exercisable until it has vested as set forth herein. IRR Option Shares shall vest and become exercisable in accordance with the following:

          (a) 18,188 IRR Option Shares shall automatically vest and become exercisable in the event the Major Investor either (i) receives at least a twenty-five percent (25%) IRR or (ii) achieves an ROI of at least 2.0x, in each case with respect to the Investment upon a Change of Control or an IPO;

          (b) An additional 18,188 IRR Option Shares shall automatically vest and become exercisable in the event the Major Investor either (i) receives at least a thirty percent (30%) IRR or (ii) achieves an ROI of at least 2.25x, in each case with respect to the Investment upon a Change of Control or an IPO; and

          (c) The remaining 18,188 IRR Option Shares shall automatically vest and become exercisable in the event the Major Investor either (i) receives at least a forty percent (40%) IRR and Cash Inflows equal to at least two times Cash Outflows or (ii) achieves an ROI of at least 2.75x, in each case with respect to the Investment upon a Change of Control or an IPO.

          2.3 Determination of Major Investor’s IRR and ROI .

          (a) The determination of the Major Investor’s IRR and ROI (and Logan’s vesting as a result thereof) shall be measured, for purposes of Sections 2.2(a)-(c) with respect to a Change of Control or an IPO, as promptly as practicable (i) upon a Change of Control and (ii) after the IPO in accordance with Section 2.3(b).

          (b) In the event of an IPO, the determination of the Major Investor’s IRR and ROI shall be determined in two (2) stages:

     (i) The IRR and ROI determinations regarding one-half (1/2) of the IRR Option Shares referred to in each of Sections 2.2(a)-(c) shall be made as of the close of business on the thirtieth day (or if not a Business Day, the next Business Day) following the effective date of the IPO based on the average of the closing prices of the Common Stock on the principal exchange or quotation system on which such shares are traded on the trading days during the thirty (30) day period following the IPO (the “ Initial Trading Price ”). Such average closing price shall be multiplied by

4


 

the number of shares of Common Stock (including shares of Common Stock exercisable pursuant to any warrants or other convertible securities but, with respect to the Preferred Stock, only Preferred Stock which has a Conversion Price (as defined in the Company’s Amended and Restated Certificate of Incorporation, as amended from time to time) that is less than the Initial Trading Price) held by the Major Investor and the result shall be treated as a Cash Inflow and shall be added to all other Cash Inflows for purposes of calculating the IRR and as a return on the Investment for purposes of calculating the ROI. If any preferred stock that is not convertible to Common Stock continues to be outstanding at the time of the determination of the IRR and ROI or if the Conversion Price of the Preferred Stock is equal to or greater than the Initial Trading Price, such preferred stock shall be valued at its liquidation preference plus any accrued but unpaid dividends and such amount shall also be added to all other Cash Inflows for purposes of calculating the IRR and treated as a return on the Investment for purposes of calculating ROI. To the extent that any such IRR Option Shares fail to vest based on such IRR and ROI determinations, such IRR Option Shares shall immediately lapse and be of no further effect.

     (ii) Vesting of the remainder of the IRR Option Shares shall be determined promptly after the Major Investor sells all of the Investment, based on the IRR and ROI taking into account the actual proceeds received by the Major Investor in such transaction or transactions in which such investment is sold. In the event that, following the IPO, the Major Investor fails to dispose of all of the Investment (such remaining portion referred to herein as the “ Unliquidated Portion ”), within two (2) years from the date of the IPO, the vesting of any remaining IRR Option Shares shall be determined as of the close of business on the second anniversary of the IPO (or if not a Business Day, the next Business Day) based upon the IRR and ROI computed assuming such Unliquidated Portion is sold at a price equal to the average closing price of the Common Stock for all trading days during the 365 days prior to such two (2) year anniversary (the “ Subsequent Trading Price ”). Such average closing price shall be multiplied by the number of shares of Common Stock that constitute the Unliquidated Portion (including shares of Common Stock exercisable pursuant to any warrants or other convertible securities but, with respect to the Preferred Stock, only Preferred Stock which has a Conversion Price that is less than the Subsequent Trading Price) held by the Major Investor and the result shall be treated as a Cash Inflow and shall be added to all other Cash Inflows for purposes of calculating the IRR and as a return on the Investment for purposes of calculating the ROI. If any preferred stock that is not convertible to Common Stock continues to be part of the Unliquidated Portion at the time of the determination of the IRR and ROI or if the Conversion Price of the Preferred Stock is equal to or greater than

5


 

the Subsequent Trading Price, such preferred stock shall be valued at its liquidation preference plus any accrued but unpaid dividends, and such amount shall also be added to all other Cash Inflows for purposes of calculating the IRR and be treated as a return on the Investment for purposes of calculating the ROI. To the extent that any IRR Option Shares fail to vest based on such IRR and ROI determinations, such IRR Option Shares shall immediately lapse and be of no further effect.

          (c) Vesting of IRR Option Shares shall occur immediately prior to, but effective only upon, the Change of Control or IPO-related event giving rise to such vesting.

          (d) IRR and ROI determinations shall give effect to any reduction of the Major Investor’s IRR or ROI on the Investment as a result of the vesting of IRR Option Shares or of any other performance-based options, incentives, bonuses, restricted stock awards or other compensation, whether awarded by the Major Investor, the Company, or any of its subsidiaries that are tied to performance.

          (e) In calculating the IRR and ROI, it shall be assumed (1) that the Major Investor owns the percentage of outstanding shares of Common Stock as if on the date the IRR Call Option and the Time Call Option were granted, such options had been granted by the Company rather than by the Major Investor and (2) that the Major Investor received the benefits of the Change of Control Transaction or the IPO on the basis of such increased number of shares. In other words, the calculation of the IRR and ROI should exclude the increased dilution suffered by the Major Investor by granting the IRR Call Option and the Time Call Option on shares owned by the Major Investor rather than having the Company grant such options with respect to authorized but unissued shares. For example, and not by way of limitation, if on the date the IRR Call Option and the Time Call Option were granted, the Major Investor owned 80 shares out of 100 outstanding shares on a Fully Diluted Basis, or 80%, and granted an option for 6 shares (6% of the outstanding shares on a Fully Diluted Basis) to Logan, for purposes of calculating the IRR and ROI it will be assumed that the Company granted the options for 6 shares and that the Major Investor owned after the grant of the options, 75.5% of the outstanding shares on a Fully Diluted Basis (80 ÷ 106) rather than 74% (74 ÷ 100) of the shares on a Fully Diluted Basis. If a Change of Control Transaction were to occur, the Major Investor would be deemed to have received an amount from the net proceeds as if the Major Investor owned 75.5% of the outstanding shares on a Fully Diluted Basis for purposes of calculating the IRR and ROI. Similarly, if there is an IPO, in determining the number of shares owned by the Major Investor and sold for purposes of Section 2.3(b) above, the Major Investor will be deemed to hold the number of shares it would have held applying the adjustments and assumptions in this Section 2.3(e). If the IRR or ROI is being calculated at time of and as a result of the disposition by the Major Investor of all of its shares or as of the second anniversary of the IPO, the Major Investor will be deemed to have sold the additional shares deemed held as a result of the application of the assumptions and adjustments in this Section 2.3(e) at the time of and for the price

6


 

realized by the Major Investor in its final sale of shares, or as contemplated by Section 2.3(b)(B), as applicable.

          2.4 Exercise by Major Investor Upon Change of Control . Upon a Change of Control (whether before or after the IPO), the Major Investor will have the right and shall have the obligation, but only to the extent that the IRR Option Shares vest upon such Change of Control, to sell in the contemplated Change of Control, at the same price and on the same terms as the Major Investor is selling its shares of Common Stock, the vested IRR Option Shares and promptly remit to Logan the net proceeds of such sale, less the aggregate per share IRR Exercise Price of such shares. The IRR and ROI of the Major Investor shall be determined, and any proceeds to which Logan is entitled shall be remitted to him, within twenty (20) days of a Change of Control transaction. To the extent the Major Investor’s IRR and ROI is dependent upon any escrow or contingent consideration, the Major Investor will recalculate its IRR and ROI at the time any escrow payments are received or contingent consideration paid and shall remit to Logan any additional net proceeds, less the aggregate per share Exercise Price of such additional shares, which are vested and sold as a result thereof.

          2.5 Exercise Upon IPO by Major Investor . At any time after the IPO, if the Major Investor is selling its entire Investment, the Major Investor shall be permitted to and shall have the obligation to sell all of its remaining shares of Common Stock, including those shares of Common Stock which may be exercisable for vested IRR Option Shares based upon the final determination of the Major Investor’s IRR and ROI (a “ Market Disposition ”). Any Market Disposition by the Major Investor shall be subject to the Major Investor’s obligation to remit to Logan the portion of the net proceeds attributable to his vested unexercised IRR Option Shares less the aggregate IRR Exercise Price thereof. In connection with a Market Disposition, the IRR and ROI of the Major Investor shall be determined, and any proceeds to which Logan is entitled shall be remitted to him, within thirty (30) days following such event.

          2.6 Exercise Procedure Generally .

          (a) At any time after any IRR Option Shares have vested, Logan may provide the Major Investor with five (5) Business Days prior written notice (the “ Exercise Notice ”) to exercise his option to purchase any IRR Option Shares that may be vested at the time. The Exercise Notice shall state the number of IRR Option Shares Logan desires to purchase and the aggregate IRR Exercise Price to be paid by Logan to the Major Investor for such shares.

          (b) The closing of any exercise of the IRR Call Option shall take place at 10:00 a.m. local time at the offices of the Major Investor, on the date specified for the pro


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more